Hypertrophic Olivary Degeneration Following Brainstem Hemorrhage in a Patient with Tremor: A Case Report with Serial MRI Follow-Up
Journal of Clinical Medicine · 12.06.2026 · 15 (12) · 4579
DOI: 10.3390/jcm15124579 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 12.06.2026. Verfasst von Seung Yoon Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, Hanyang University Medical Center, Seoul 04763, Republic of Korea. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Hypertrophic olivary degeneration (HOD) is a rare neurological condition resulting from trans-synaptic degeneration of the inferior olivary nucleus (ION) following disruption of the dentato-rubro-olivary pathway, also known as the Guillain–Mollaret triangle (GMT). Although the clinical and radiologic features of HOD have been previously described, the precise temporal correlation between clinical symptom onset and manifestations on magnetic resonance imaging (MRI) remains difficult to establish, and the factors contributing to accelerated disease progression are poorly understood. Case Presentation: A 43-year-old male presented with intracerebral hemorrhage involving the left midbrain, bilateral pons, and cerebellum. Serial MRI was prospectively performed starting four weeks post-hemorrhage, at which time no signal abnormalities were detected in the ION. However, at 9 weeks, T2 hyperintensity first emerged in the bilateral ION. Approximately 2 weeks after this finding, the patient developed characteristic palatal and lingual tremors, accompanied by a dissociated vertical pendular nystagmus that was predominantly monocular (right eye). In addition, severe dysphagia was also noted, with videofluoroscopic swallowing study (VFSS) showing aspiration across all diets. A subsequent MRI obtained at 13 weeks post-insult (two weeks after tremor onset) revealed newly developed bilateral ION hypertrophy, with the maximal diameter increasing from a 5 mm baseline to 7 mm. Follow-up MRI at 17 weeks post-hemorrhage revealed further progression with increased hypertrophy and signal intensity. Dysphagia persisted throughout the clinical course, ultimately necessitating percutaneous endoscopic gastrostomy (PEG) tube insertion.
Conclusions
This case provides rare, longitudinal documentation of the clinico-radiologic progression of HOD, facilitated by a pre-insult baseline MRI and prospective serial imaging. Our findings provide a detailed timeline of the transition from signal abnormality to hypertrophy in correlation with clinical symptom emergence.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, Hanyang University Medical Center, Seoul 04763, Republic of Korea.
- Department of Rehabilitation Medicine, Hanyang University Guri Hospital, Guri 11923, Republic of Korea.
- Department of Neurosurgery, Hanyang University Guri Hospital, Guri 11923, Republic of Korea.
ORCID-Profile: Seung Yoon Choi, Yeo Joon Yun
Zitieren
APA
Choi, S. Y., Lee, J. W., Choi, Y. J., Cheong, J. H., & Yun, Y. J. (2026). Hypertrophic Olivary Degeneration Following Brainstem Hemorrhage in a Patient with Tremor: A Case Report with Serial MRI Follow-Up. Journal of Clinical Medicine, 15(12), 4579. https://doi.org/10.3390/jcm15124579
Vancouver
Choi SY, Lee JW, Choi YJ, Cheong JH, Yun YJ. Hypertrophic Olivary Degeneration Following Brainstem Hemorrhage in a Patient with Tremor: A Case Report with Serial MRI Follow-Up. Journal of Clinical Medicine. 2026;15(12):4579. doi:10.3390/jcm15124579
BibTeX
@article{Choi2026,
author = {Choi, Seung Yoon and Lee, Ji Woo and Choi, Yu Jin and Cheong, Jin Hwan and Yun, Yeo Joon},
title = {Hypertrophic Olivary Degeneration Following Brainstem Hemorrhage in a Patient with Tremor: A Case Report with Serial MRI Follow-Up},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {12},
pages = {4579},
doi = {10.3390/jcm15124579}
}
EUVIMED